Patient Parameters

Enter visual fields in chronological order.

Date (YYYY-MM) MD (dB) Reliability i
Clinical modifiers
VF Progression Analysis ·
—
dB / year
—
—
i
Share feedback or report a case
MethodLinear regression (MD ~ time, dB/year)
Date resolutionMonth-level (YYYY-MM). Day set to 01.
Plausible range−35 to +2 dB
Adequate datan ≥ 5 visual fields AND follow-up ≥ 24 months
Limited dataOtherwise: n ≥ 4 visual fields AND follow-up ≥ 12 months
Insufficient dataOtherwise: n < 4 OR follow-up < 12 months
No progression detectedslope > −0.5 dB/year
Suspicious trend−1.0 < slope ≤ −0.5 dB/year
Progressing (fast)−2.0 < slope ≤ −1.0 dB/year
Progressing (very fast)slope ≤ −2.0 dB/year
AlgorithmCLA v2.2.0
Limitations:
Uses global MD only — focal progression may not be captured. No learning effect correction. No pointwise analysis. Short series may show amplified slope variance.

Evidence-informed functional progression analysis based on serial visual field data. Does not replace clinical judgment or comprehensive perimetric evaluation.

This tool analyses longitudinal visual field Mean Deviation values using linear regression to estimate the rate of functional change over time. Classification is based on deterministic rule-based logic and is intended as a structured decision support aid, not as a standalone diagnostic conclusion.

Visual field interpretation may be affected by test reliability, short-term fluctuation, media opacity, cognitive state, disease stage, and instrument variability. MD slope estimation requires adequate serial data; results from small or short series should be interpreted with caution. Global MD does not capture focal progression.

The clinician retains full responsibility for all diagnostic and therapeutic decisions. This tool is intended as a decision-support aid, consistent with current glaucoma guidelines, and is not a substitute for clinical evaluation. Not intended for patient self-use.

  • Heijl A, Leske MC, Bengtsson B, et al. Reduction of intraocular pressure and glaucoma progression: results from the Early Manifest Glaucoma Trial. Arch Ophthalmol. 2002;120(10):1268–1279.
  • Chauhan BC, Garway-Heath DF, Goñi FJ, et al. Practical recommendations for measuring rates of visual field change in glaucoma. Br J Ophthalmol. 2008;92(4):569–573.
  • Bengtsson B, Heijl A. A visual field index for calculation of glaucoma rate of progression. Am J Ophthalmol. 2008;145(2):343–353.
  • Gedde SJ, Vinod K, Wright MM, et al. Primary open-angle glaucoma preferred practice pattern. Ophthalmology. 2021;128(1S):P71–P150.
  • European Glaucoma Society. Terminology and guidelines for glaucoma, 6th edition. Br J Ophthalmol. 2025;109(Suppl 1):1–212.
  • v1.1Jul 2026
    • Stable output wording clarified as No progression detected
    • Interpretation expanded to acknowledge cataract, media opacity, macular pathology, and other non-glaucomatous confounders
    • Reliability-limited series with fewer than two interpretable fields now return an aligned unclassifiable structured output
    • Borderline reliability is now preserved and processed explicitly by the pure M3 engine
    • Borderline final fields reduce confidence without automatically lowering clinical risk
    • UI, copied result, localStorage output, and M5 contract aligned for the revised reliability pathways
    • Algorithm updated to v2.1.0; regression method and numerical progression thresholds unchanged
    • Final integrity patch: stale-result invalidation, preservation of deferred interpretation notes, and reliability wording cleanup
    • Algorithm updated to v2.2.0: canonical inconsistent_functional_pattern flag added to the M3 suite-export contract (localStorage payload only), generated from the existing inconsistency/oscillation detection; no classification, risk, confidence, or visible UI rule changed
  • v1.0Apr 2026
    • First public release
    • Rule-based classification of MD slope into four progression categories
    • Reliability-adjusted analysis (Good / Borderline / Low)
    • Confidence level and Clinical Risk outputs
    • Structured interpretation text for each result
    • Clinical modifiers: central threat to fixation, monocular status
    • Sparkline chart and 95% CI in result card
    • Mobile-optimised UI with gap warning and Excel-style data entry